DOCSLIB.ORG

Inflammation Novel Mechanism to Cope

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Inflammation Novel Mechanism to Cope Immune Suppression via Glucocorticoid-Stimulated Monocytes: A Novel Mechanism To Cope with Inflammation This information is current as of September 29, 2021. Georg Varga, Jan Ehrchen, Anne Brockhausen, Toni Weinhage, Nadine Nippe, Michael Belz, Athanasios Tsianakas, Matthias Ross, Dominik Bettenworth, Tilmann Spieker, Marc Wolf, Ralph Lippe, Klaus Tenbrock, Pieter J. M. Leenen, Johannes Roth and Cord Sunderkötter Downloaded from J Immunol 2014; 193:1090-1099; Prepublished online 2 July 2014; doi: 10.4049/jimmunol.1300891 http://www.jimmunol.org/content/193/3/1090 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2014/07/02/jimmunol.130089 Material 1.DCSupplemental References This article cites 51 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/193/3/1090.full#ref-list-1 by guest on September 29, 2021 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Immune Suppression via Glucocorticoid-Stimulated Monocytes: A Novel Mechanism To Cope with Inflammation Georg Varga,*,†,‡,1 Jan Ehrchen,*,†,1 Anne Brockhausen,*,† Toni Weinhage,‡ Nadine Nippe,*,† Michael Belz,*,† Athanasios Tsianakas,† Matthias Ross,x Dominik Bettenworth,x Tilmann Spieker,{ Marc Wolf,* Ralph Lippe,* Klaus Tenbrock,‖ Pieter J. M. Leenen,# Johannes Roth,* and Cord Sunderko¨tter*,† Glucocorticoids (GCs) are used as first-line therapies for generalized suppression of inflammation (e.g., allergies or autoimmune diseases), but their long-term use is limited by severe side effects. Our previous work revealed that GCs induced a stable anti- inflammatory phenotype in monocytes, the GC-stimulated monocytes (GCsMs) that we exploited for targeted GC-mediated therapeutic effects. We demonstrate that GCsMs interact with T cells in suppressing proliferation, as well as cytokine release Downloaded from of CD8+ and, especially, CD4+ T cells in vitro, and that they support generation of Foxp3+ cells. Therefore, we tested their immunosuppressive potential in CD4+ T cell–induced colitis in vivo. We found that injection of GCsMs into mice with severe colitis abolished the inflammation and resulted in significant clinical improvement within a few days. T cells recovered from GCsM-treated mice exhibited reduced secretion of proinflammatory cytokines IFN-g and IL-17. Furthermore, clusters of Foxp3+ CD4+ T cells were detectable at local sites of inflammation in the colon. Thus, GCsMs are able to modify T cell responses in vitro and in vivo, as well as to downregulate and clinically cure severe T cell–mediated colitis. The Journal of Immunology, 2014, 193: 1090–1099. http://www.jimmunol.org/ lucocorticoids (GCs) are the most widely used agents for flammatory cytokines as the result of an interaction between GC suppression of both acute and chronic inflammation, but receptor monomers and proinflammatory transcription factors, such G their wide spectrum of adverse effects limits long-term as NF-kB or AP-1, in a process called “transrepression” (4, 5). GCs treatment. Their clinical efficacy in treating inflammation has also induce anti-inflammatory mediators in monocytes/macrophages been ascribed mainly to their direct inhibitory effects on activated (e.g., annexin A1) (6, 7). immune cells, such as T cells (1) or monocytes/macrophages (2, 3). Moreover, we demonstrated previously that GCs not only down- In monocytes and macrophages they inhibit production of proin- regulate proinflammatory cytokines, they also generate a functionally active, anti-inflammatory phenotype in human monocytes that sup- by guest on September 29, 2021 presses inflammatory processes and, thus, induces resolution of in- *Institute of Immunology, University of Muenster, 48149 Muenster, Germany; flammation (8–10). †Department of Dermatology, University of Muenster, 48149 Muenster, Germany; ‡Pediatric Rheumatology and Immunology, University of Muenster, 48149 Muenster, Monocytes represent a central part of innate immunity. After Germany; xDepartment of Medicine B, University of Muenster, 48149 Muenster, differentiation from stem cells in the bone marrow, monocytes enter Germany; {Institute of Pathology, University of Muenster, 48149 Muenster, Germany; ‖ the circulation and are present in the blood until they migrate into Department of Pediatrics, University of Aachen, Rheinisch Westfa¨lische Technische Hochschule, 52062 Aachen, Germany; and #Department of Immunology, Erasmus tissues where they differentiate into macrophages or dendritic cells Medical Center, 3000 Rotterdam, the Netherlands (DCs). These cells give rise to subtypes that are crucial for nearly 1G.V. and J.E. contributed equally to this work. every step of an immune reaction, including the initiation of an Received for publication April 3, 2013. Accepted for publication May 16, 2014. adaptive immune response, clearance of infectious agents, and res- This work was supported by grants from the Deutsche Forschungsgemeinschaft olution of inflammation (11–16). Subpopulations have been defined (DFG SU 195/3-1 to C.S. and G.V.; DFG SU 195/3-2 to C.S., G.V., and A.B; at the level of circulating monocytes in the human (14) and in the DFG DA 1161/4-1 to T.W.; and DFG EH 397/1-1 to J.E. and C.S.), as well as by murine system (17–19). Reflected by their expression level of IMF VA 22 07 07, IZKF RO 20120, and IZKF Eh2/019/11 (to C.S. and J.E.) (Uni- versity of Muenster). N.N. was supported by SkinStaph Grant FKZ: 01kI07100 from CX3CR1 and CCR2 (as well as Ly6C in mice), monocytes either Bundesministerium fur€ Forschung und Bildung. represent a subtype that selectively migrates into inflamed tissue G.V. and J.E. designed research, performed research, and wrote the manuscript; A.B., M.W., (17, 18, 20) or that forms tissue macrophages and DCs under N.N.,M.B.,A.T.,M.R.,T.S.,R.L.,D.B.,andT.W.performedresearch;K.T.andP.J.M.L. steady-state conditions (reviewed in Refs. 12, 14, 19). designed research; and J.R. and C.S. designed research and wrote the manuscript. In analogy to our studies on human monocytes, we previously The sequences presented in this article have been submitted to the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54778) under ac- defined a GC-stimulated murine monocyte subset generated cession number GSE54778. from bone marrow–derived monocytes (21). These murine GC- Address correspondence and reprint requests to Dr. Cord Sunderko¨tter, Department stimulated monocytes (GCsMs) exhibit a stable and distinct phe- of Dermatology, University of Muenster, Von-Esmarch-Straße 58, D-48149 Muen- notype and share with their human counterparts properties such as ster, Germany. E-mail address: [email protected] production of anti-inflammatory mediators and increased migra- The online version of this article contains supplemental material. tory potential (8, 21). In the murine system, GCsMs are charac- Abbreviations used in this article: Ctr-Mo, control monocyte; DC, dendritic cell; GC, low 2 med/high + glucocorticoid; GCsM, glucocorticoid-stimulated monocyte; GITR, glucocorticoid- terized phenotypically as CX3CR1 CCR2 Ly6C CD80 + + induced TNFR-related protein; GO, Gene Ontology; LPMC, lamina propria mono- CD124 CD163 cells (21). This cell surface signature and in- nuclear cell; MDSC, myeloid-derived suppressor cell; MLN, mesenteric lymph node; creased expression of the IL-4Ra-chain (CD124) suggest simi- Treg, regulatory T cell. larity of GCsM to so-called “myeloid-derived suppressor cells” Copyright Ó 2014 by The American Association of Immunologists, Inc. 0022-1767/14/$16.00 (MDSCs) that were described to suppress T cells and adaptive www.jimmunol.org/cgi/doi/10.4049/jimmunol.1300891 The Journal of Immunology 1091 immune responses (22, 23). Therefore, we hypothesized that analyzed by GCOS Software (Affymetrix), using data from corresponding GCsMs also contribute to regulation of adaptive immune responses, control samples as baseline, and further evaluated statistically, as described especially those mediated by effector T cells. previously (8). They were submitted to the Gene Expression Omnibus under accession number GSE54778. In this study, we approached this hypothesis by genome-wide We retained only genes that were significantly regulated in every ex- expression screening of murine GCsMs and ensuing functional periment (change p value , 0.05; fold change .2, expression over clustering. The data indicated that GC treatment significantly background), as well as in the complete set of experiments (fold-change . , affected the capacity of monocytes to interact with T cells. In agree- 2.0, p value 0.05, paired t test). ment with this, we identified GCsMs as potent suppressors of both Functional clustering CD8+ and CD4+ effector T cell activation in vitro and in vivo.
Load more

Recommended publications
  • Prox1regulates the Subtype-Specific Development of Caudal Ganglionic
    The Journal of Neuroscience, September 16, 2015 • 35(37):12869–12889 • 12869 Development/Plasticity/Repair Prox1 Regulates the Subtype-Specific Development of Caudal Ganglionic Eminence-Derived GABAergic Cortical Interneurons X Goichi Miyoshi,1 Allison Young,1 Timothy Petros,1 Theofanis Karayannis,1 Melissa McKenzie Chang,1 Alfonso Lavado,2 Tomohiko Iwano,3 Miho Nakajima,4 Hiroki Taniguchi,5 Z. Josh Huang,5 XNathaniel Heintz,4 Guillermo Oliver,2 Fumio Matsuzaki,3 Robert P. Machold,1 and Gord Fishell1 1Department of Neuroscience and Physiology, NYU Neuroscience Institute, Smilow Research Center, New York University School of Medicine, New York, New York 10016, 2Department of Genetics & Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, 3Laboratory for Cell Asymmetry, RIKEN Center for Developmental Biology, Kobe 650-0047, Japan, 4Laboratory of Molecular Biology, Howard Hughes Medical Institute, GENSAT Project, The Rockefeller University, New York, New York 10065, and 5Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 Neurogliaform (RELNϩ) and bipolar (VIPϩ) GABAergic interneurons of the mammalian cerebral cortex provide critical inhibition locally within the superficial layers. While these subtypes are known to originate from the embryonic caudal ganglionic eminence (CGE), the specific genetic programs that direct their positioning, maturation, and integration into the cortical network have not been eluci- dated. Here, we report that in mice expression of the transcription factor Prox1 is selectively maintained in postmitotic CGE-derived cortical interneuron precursors and that loss of Prox1 impairs the integration of these cells into superficial layers. Moreover, Prox1 differentially regulates the postnatal maturation of each specific subtype originating from the CGE (RELN, Calb2/VIP, and VIP).
    [Show full text]
  • And Represses TNF Gene Expression Activating Transcription Factor-2
    Histone Deacetylase 3, a Class I Histone Deacetylase, Suppresses MAPK11-Mediated Activating Transcription Factor-2 Activation and Represses TNF Gene Expression This information is current as of September 25, 2021. Ulrich Mahlknecht, Jutta Will, Audrey Varin, Dieter Hoelzer and Georges Herbein J Immunol 2004; 173:3979-3990; ; doi: 10.4049/jimmunol.173.6.3979 http://www.jimmunol.org/content/173/6/3979 Downloaded from References This article cites 45 articles, 31 of which you can access for free at: http://www.jimmunol.org/content/173/6/3979.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 25, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Histone Deacetylase 3, a Class I Histone Deacetylase, Suppresses MAPK11-Mediated Activating Transcription Factor-2 Activation and Represses TNF Gene Expression1 Ulrich Mahlknecht,2* Jutta Will,* Audrey Varin,† Dieter Hoelzer,* and Georges Herbein2† During inflammatory events, the induction of immediate-early genes, such as TNF-␣, is regulated by signaling cascades including the JAK/STAT, NF-␬B, and the p38 MAPK pathways, which result in phosphorylation-dependent activation of transcription factors.
    [Show full text]
  • Targeting Endothelial Kruppel-Like Factor 2 (KLF2) in Arteriovenous
    Targeting Endothelial Krüppel-like Factor 2 (KLF2) in Arteriovenous Fistula Maturation Failure A dissertation submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY (Ph.D.) in the Biomedical Engineering Program Department of Biomedical Engineering College of Engineering and Applied Science 2018 by Keith Louis Saum B.S., Wright State University, 2012 Dissertation Committee: Albert Phillip Owens III, Ph.D. (Committee Chair) Begona Campos-Naciff, Ph.D Christy Holland, Ph.D. Daria Narmoneva, Ph.D. Prabir Roy-Chaudhury, M.D., Ph.D Charuhas Thakar, M.D. Abstract The arteriovenous fistula (AVF) is the preferred form of vascular access for hemodialysis. However, 25-60% of AVFs fail to mature to a state suitable for clinical use, resulting in significant morbidity, mortality, and cost for end-stage renal disease (ESRD) patients. AVF maturation failure is recognized to result from changes in local hemodynamics following fistula creation which lead to venous stenosis and thrombosis. In particular, abnormal wall shear stress (WSS) is thought to be a key stimulus which alters endothelial function and promotes AVF failure. In recent years, the transcription factor Krüppel-like factor-2 (KLF2) has emerged as a key regulator of endothelial function, and reduced KLF2 expression has been shown to correlate with disturbed WSS and AVF failure. Given KLF2’s importance in regulating endothelial function, the objective of this dissertation was to investigate how KLF2 expression is regulated by the hemodynamic and uremic stimuli within AVFs and determine if loss of endothelial KLF2 is responsible for impaired endothelial function.
    [Show full text]
  • Transcriptome Sequencing and Genome-Wide Association Analyses Reveal Lysosomal Function and Actin Cytoskeleton Remodeling in Schizophrenia and Bipolar Disorder
    Molecular Psychiatry (2015) 20, 563–572 © 2015 Macmillan Publishers Limited All rights reserved 1359-4184/15 www.nature.com/mp ORIGINAL ARTICLE Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder Z Zhao1,6,JXu2,6, J Chen3,6, S Kim4, M Reimers3, S-A Bacanu3,HYu1, C Liu5, J Sun1, Q Wang1, P Jia1,FXu2, Y Zhang2, KS Kendler3, Z Peng2 and X Chen3 Schizophrenia (SCZ) and bipolar disorder (BPD) are severe mental disorders with high heritability. Clinicians have long noticed the similarities of clinic symptoms between these disorders. In recent years, accumulating evidence indicates some shared genetic liabilities. However, what is shared remains elusive. In this study, we conducted whole transcriptome analysis of post-mortem brain tissues (cingulate cortex) from SCZ, BPD and control subjects, and identified differentially expressed genes in these disorders. We found 105 and 153 genes differentially expressed in SCZ and BPD, respectively. By comparing the t-test scores, we found that many of the genes differentially expressed in SCZ and BPD are concordant in their expression level (q ⩽ 0.01, 53 genes; q ⩽ 0.05, 213 genes; q ⩽ 0.1, 885 genes). Using genome-wide association data from the Psychiatric Genomics Consortium, we found that these differentially and concordantly expressed genes were enriched in association signals for both SCZ (Po10 − 7) and BPD (P = 0.029). To our knowledge, this is the first time that a substantially large number of genes show concordant expression and association for both SCZ and BPD. Pathway analyses of these genes indicated that they are involved in the lysosome, Fc gamma receptor-mediated phagocytosis, regulation of actin cytoskeleton pathways, along with several cancer pathways.
    [Show full text]
  • Mechanisms of Synaptic Plasticity Mediated by Clathrin Adaptor-Protein Complexes 1 and 2 in Mice
    Mechanisms of synaptic plasticity mediated by Clathrin Adaptor-protein complexes 1 and 2 in mice Dissertation for the award of the degree “Doctor rerum naturalium” at the Georg-August-University Göttingen within the doctoral program “Molecular Biology of Cells” of the Georg-August University School of Science (GAUSS) Submitted by Ratnakar Mishra Born in Birpur, Bihar, India Göttingen, Germany 2019 1 Members of the Thesis Committee Prof. Dr. Peter Schu Institute for Cellular Biochemistry, (Supervisor and first referee) University Medical Center Göttingen, Germany Dr. Hans Dieter Schmitt Neurobiology, Max Planck Institute (Second referee) for Biophysical Chemistry, Göttingen, Germany Prof. Dr. med. Thomas A. Bayer Division of Molecular Psychiatry, University Medical Center, Göttingen, Germany Additional Members of the Examination Board Prof. Dr. Silvio O. Rizzoli Department of Neuro-and Sensory Physiology, University Medical Center Göttingen, Germany Dr. Roland Dosch Institute of Developmental Biochemistry, University Medical Center Göttingen, Germany Prof. Dr. med. Martin Oppermann Institute of Cellular and Molecular Immunology, University Medical Center, Göttingen, Germany Date of oral examination: 14th may 2019 2 Table of Contents List of abbreviations ................................................................................. 5 Abstract ................................................................................................... 7 Chapter 1: Introduction ............................................................................
    [Show full text]
  • Global Mef2 Target Gene Analysis in Skeletal and Cardiac Muscle
    GLOBAL MEF2 TARGET GENE ANALYSIS IN SKELETAL AND CARDIAC MUSCLE STEPHANIE ELIZABETH WALES A DISSERTATION SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN BIOLOGY YORK UNIVERSITY TORONTO, ONTARIO FEBRUARY 2016 © Stephanie Wales 2016 ABSTRACT A loss of muscle mass or function occurs in many genetic and acquired pathologies such as heart disease, sarcopenia and cachexia which are predominantly found among the rapidly increasing elderly population. Developing effective treatments relies on understanding the genetic networks that control these disease pathways. Transcription factors occupy an essential position as regulators of gene expression. Myocyte enhancer factor 2 (MEF2) is an important transcription factor in striated muscle development in the embryo, skeletal muscle maintenance in the adult and cardiomyocyte survival and hypertrophy in the progression to heart failure. We sought to identify common MEF2 target genes in these two types of striated muscles using chromatin immunoprecipitation and next generation sequencing (ChIP-seq) and transcriptome profiling (RNA-seq). Using a cell culture model of skeletal muscle (C2C12) and primary cardiomyocytes we found 294 common MEF2A binding sites within both cell types. Individually MEF2A was recruited to approximately 2700 and 1600 DNA sequences in skeletal and cardiac muscle, respectively. Two genes were chosen for further study: DUSP6 and Hspb7. DUSP6, an ERK1/2 specific phosphatase, was negatively regulated by MEF2 in a p38MAPK dependent manner in striated muscle. Furthermore siRNA mediated gene silencing showed that MEF2D in particular was responsible for repressing DUSP6 during C2C12 myoblast differentiation. Using a p38 pharmacological inhibitor (SB 203580) we observed that MEF2D must be phosphorylated by p38 to repress DUSP6.
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • In Renal Cell Carcinoma
    biomedicines Article Regulation of Oncogenic Targets by the Tumor-Suppressive miR-139 Duplex (miR-139-5p and miR-139-3p) in Renal Cell Carcinoma Reona Okada 1, Yusuke Goto 1,2, Yasutaka Yamada 1,2, Mayuko Kato 1,2, Shunichi Asai 1, Shogo Moriya 3, Tomohiko Ichikawa 2 and Naohiko Seki 1,* 1 Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan; [email protected] (R.O.); [email protected] (Y.G.); [email protected] (Y.Y.); [email protected] (M.K.); [email protected] (S.A.) 2 Department of Urology, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan; [email protected] 3 Department of Biochemistry and Genetics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-43-226-2971 Received: 20 November 2020; Accepted: 10 December 2020; Published: 12 December 2020 Abstract: We previously found that both the guide and passenger strands of the miR-139 duplex (miR-139-5p and miR-139-3p, respectively) were downregulated in cancer tissues. Analysis of TCGA datasets revealed that low expression of miR-139-5p (p < 0.0001) and miR-139-3p (p < 0.0001) was closely associated with 5-year survival rates of patients with renal cell carcinoma (RCC). Ectopic expression assays showed that miR-139-5p and miR-139-3p acted as tumor-suppressive miRNAs in RCC cells. Here, 19 and 22 genes were identified as putative targets of miR-139-5p and miR-139-3p in RCC cells, respectively.
    [Show full text]
  • Clinical, Cellular, and Neuropathological Consequences Of
    Clinical, cellular, and neuropathological consequences of AP1S2 mutations: further delineation of a recognizable X-linked mental retardation syndrome Guntram Borck, Anahi Mollà-Herman, Nathalie Boddaert, Ferechte Encha-Razavi, Anne Philippe, Laurence Robel, Isabelle Desguerre, Francis Brunelle, Alexandre Benmerah, Arnold Munnich, et al. To cite this version: Guntram Borck, Anahi Mollà-Herman, Nathalie Boddaert, Ferechte Encha-Razavi, Anne Philippe, et al.. Clinical, cellular, and neuropathological consequences of AP1S2 mutations: further delineation of a recognizable X-linked mental retardation syndrome. Human Mutation, Wiley, 2008, 29 (7), pp.966-974. 10.1002/humu.20531. hal-02044435 HAL Id: hal-02044435 https://hal.archives-ouvertes.fr/hal-02044435 Submitted on 2 Apr 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. HUMANMUTATION29(7),966^974,2008 RESEARCH ARTICLE Clinical, Cellular, and Neuropathological Consequences of AP1S2 Mutations: Further Delineation of a Recognizable X-Linked Mental Retardation Syndrome Guntram Borck,1 Anahi Molla`-Herman,6,7
    [Show full text]
  • AP1 Complex Subunit Sigma-2 / AP1S2 (1-157, His-Tag) Human Protein Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for AR39026PU-N AP1 complex subunit sigma-2 / AP1S2 (1-157, His-tag) Human Protein Product data: Product Type: Recombinant Proteins Description: AP1 complex subunit sigma-2 / AP1S2 (1-157, His-tag) human recombinant protein, 50 µg Species: Human Expression Host: E. coli Tag: His-tag Predicted MW: 20.7 kDa Concentration: lot specific Purity: >85% Buffer: Presentation State: Purified State: Liquid purified protein Buffer System: 20mM Tris-HCl buffer (pH 8.0) containing 40% glycerol, 0.1M NaCl, 2mM DTT Preparation: Liquid purified protein Protein Description: Recombinant human AP1S2 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography. Storage: Store undiluted at 2-8°C for up to two weeks or (in aliquots) at -20°C or -70°C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. RefSeq: NP_001259000 Locus ID: 8905 UniProt ID: A0A5F9ZHW1 Cytogenetics: Xp22.2 Synonyms: DC22; MRX59; MRXS5; MRXS21; MRXSF; PGS; SIGMA1B This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 AP1 complex subunit sigma-2 / AP1S2 (1-157, His-tag) Human Protein – AR39026PU-N Summary: Adaptor protein complex 1 is found at the cytoplasmic face of coated vesicles located at the Golgi complex, where it mediates both the recruitment of clathrin to the membrane and the recognition of sorting signals within the cytosolic tails of transmembrane receptors.
    [Show full text]
  • Cortical Foxp2 Supports Behavioral Flexibility and Developmental Dopamine D1 Receptor Expression
    bioRxiv preprint doi: https://doi.org/10.1101/624973; this version posted May 2, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Cortical Foxp2 supports behavioral flexibility and developmental dopamine D1 receptor expression Marissa Co, Stephanie L. Hickey, Ashwinikumar Kulkarni, Matthew Harper, Genevieve Konopka* Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, USA *Correspondence: [email protected] Contact information Genevieve Konopka, Ph.D. Department of Neuroscience, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., ND4.300, Dallas, TX 75390-9111 TEL: 214-648-5135, FAX: 214-648-1801, Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/624973; this version posted May 2, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract FoxP2 encodes a forkhead box transcription factor required for the development of neural circuits underlying language, vocalization, and motor-skill learning. Human genetic studies have associated FOXP2 variation with neurodevelopmental disorders (NDDs), and within the cortex, it is coexpressed and interacts with other NDD-associated transcription factors. Cortical Foxp2 is required in mice for proper social interactions, but its role in other NDD-relevant behaviors and molecular pathways is unknown.
    [Show full text]
  • Foxp2 Loss of Function Increases Striatal Direct Pathway Inhibition Via Increased GABA Release
    Brain Structure and Function https://doi.org/10.1007/s00429-018-1746-6 ORIGINAL ARTICLE Foxp2 loss of function increases striatal direct pathway inhibition via increased GABA release Jon‑Ruben van Rhijn1,2,3 · Simon E. Fisher3,4 · Sonja C. Vernes2,4 · Nael Nadif Kasri1,5 Received: 8 March 2018 / Accepted: 31 August 2018 © The Author(s) 2018 Abstract Heterozygous mutations of the Forkhead-box protein 2 (FOXP2) gene in humans cause childhood apraxia of speech. Loss of Foxp2 in mice is known to affect striatal development and impair motor skills. However, it is unknown if striatal excitatory/ inhibitory balance is affected during development and if the imbalance persists into adulthood. We investigated the effect of reduced Foxp2 expression, via a loss-of-function mutation, on striatal medium spiny neurons (MSNs). Our data show that heterozygous loss of Foxp2 decreases excitatory (AMPA receptor-mediated) and increases inhibitory (GABA receptor-medi- ated) currents in D1 dopamine receptor positive MSNs of juvenile and adult mice. Furthermore, reduced Foxp2 expression increases GAD67 expression, leading to both increased presynaptic content and release of GABA. Finally, pharmacological blockade of inhibitory activity in vivo partially rescues motor skill learning deficits in heterozygous Foxp2 mice. Our results suggest a novel role for Foxp2 in the regulation of striatal direct pathway activity through managing inhibitory drive. Keywords Foxp2 · Excitatory-inhibitory balance · Neurodevelopment · D1R-MSN · Striatum Introduction Balanced neuronal activity between cortex, striatum and Sonja C. Vernes and Nael Nadif Kasri contributed equally to this thalamus is essential for the generation of voluntary move- work. ments (Shepherd 2013). Imbalanced activity within the stria- tum is known to disrupt complex motor behaviors, such as Electronic supplementary material The online version of this the production of spoken language (Peach 2004; Square- article (https ://doi.org/10.1007/s0042 9-018-1746-6) contains supplementary material, which is available to authorized users.
    [Show full text]